Besifovir
From WikiMD's WELLNESSPEDIA
| Besifovir | |
|---|---|
| Besifovir.svg | |
| INN | |
| Drug class | |
| Routes of administration | Oral |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 441785-25-7 |
| PubChem | 5270766 |
| DrugBank | |
| ChemSpider | 4435660 |
| KEGG | |
Besifovir (INN) is an investigational medication to treat hepatitis B virus (HBV) infection.
It is a novel and potent acyclic nucleotide phosphonate with a similar chemical structure to adefovir and tenofovir.[1]
References[edit]
- ↑ "Hepatitis B virus: new therapeutic perspectives".Liver Int..4 January 2016;36(Supplement S1)
- 85–92.doi:10.1111/liv.13003.PMID:26725903.
-
Besifovir
